Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse embryonic fibroblasts through the miR-34a and p53 pathways. 2012

Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, China.

Forced-expression of transcription factors can reprogram somatic cells into induced pluripotent stem cells (iPSC). Recent studies show that the reprogramming efficiency can be improved by inclusion of small molecules that regulate chromatin modifying enzymes. We report here that sirtuin 1 (SIRT1), a member of the sirtuin family of NAD(+)-dependent protein deacetylases, is involved in iPSC formation. By using an efficient mouse secondary fibroblast reprogramming system with doxycycline (DOX) inducible Yamanaka's transcription factors delivered by piggyBac (PB) transposition (2°F/1B MEF), we show that SIRT1 knockdown decreased while resveratrol (RSV) increased the efficiency of iPSC formation. The treatments were associated with altered acetylated p53 and its downstream Nanog but not p21 expression. The stimulatory effect was also confirmed by SIRT1 over-expression, which stimulated the formation of colonies with induced Nanog and reduced p21 expression. Furthermore, the effects of RSV and SIRT1 knockdown on reprogramming were most pronounced during the initiation phase of reprogramming. MicroRNA-34a is a known regulator of SIRT1. Its inhibitor increased, while its mimics reduced iPSC formation. The stimulatory effect of SIRT1 during reprogramming was also confirmed in the primary MEF. RSV increased while tenovin-6, a small molecule that activates p53 through SIRT1 inhibition, suppressed reprogramming. In conclusion, SIRT1 enhances iPSC generation, in part, through deacetylation of p53, inhibition of p21 and enhancement of Nanog expression.

UI MeSH Term Description Entries
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
January 2013, Methods in molecular biology (Clifton, N.J.),
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
May 2017, Stem cell research,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
August 2013, Nature protocols,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
January 2015, Methods in molecular biology (Clifton, N.J.),
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
February 2015, Cell proliferation,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
January 2008, Nature biotechnology,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
May 2014, Cell biology international,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
June 2016, Investigative ophthalmology & visual science,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
February 2008, Proceedings of the National Academy of Sciences of the United States of America,
Yin Lau Lee, and Qian Peng, and Sze Wan Fong, and Andy C H Chen, and Kai Fai Lee, and Ernest H Y Ng, and Andras Nagy, and William S B Yeung
August 2012, Stem cells (Dayton, Ohio),
Copied contents to your clipboard!